{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:07:56Z","timestamp":1793225276374,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["P30 AR057230"],"award-info":[{"award-number":["P30 AR057230"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["R01 AR064327"],"award-info":[{"award-number":["R01 AR064327"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["R33 NS102838"],"award-info":[{"award-number":["R33 NS102838"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtn.2020.08.031","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:45:00Z","timestamp":1598661900000},"page":"500-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells"],"prefix":"10.1016","volume":"22","author":[{"given":"Kasturi","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April D.","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-0780","authenticated-orcid":false,"given":"Tejvir S.","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2020.08.031_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2020.08.031_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2020.08.031_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","article-title":"The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein","volume":"53","author":"Koenig","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib6","doi-asserted-by":"crossref","first-page":"28419","DOI":"10.1074\/jbc.273.43.28419","article-title":"A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction","volume":"273","author":"Amann","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2020.08.031_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mus.880170103","article-title":"Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies","volume":"17","author":"Matsumura","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2020.08.031_bib8","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2020.08.031_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","article-title":"Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage","volume":"80","author":"Campbell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0166-2236(88)90006-9","article-title":"Molecular biology of Duchenne muscular dystrophy","volume":"11","author":"Brown","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtn.2020.08.031_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-7374-3_2","article-title":"Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy","volume":"1687","author":"Tsuda","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2020.08.031_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1345","article-title":"Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology","volume":"12","author":"Alter","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2020.08.031_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/mt.2011.248","article-title":"Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy","volume":"20","author":"Cirak","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2020.08.031_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2020.08.031_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2012.04.078","article-title":"Gene therapy for muscular dystrophy: lessons learned and path forward","volume":"527","author":"Mendell","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtn.2020.08.031_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward Gene Therapy for Duchenne Muscular Dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2020.08.031_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2020.08.031_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2020.08.031_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/339055a0","article-title":"An autosomal transcript in skeletal muscle with homology to dystrophin","volume":"339","author":"Love","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2020.08.031_bib24","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1016\/S0021-9258(17)44816-2","article-title":"Identification of a chromosome 6-encoded dystrophin-related protein","volume":"265","author":"Khurana","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2020.08.031_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/360591a0","article-title":"Primary structure of dystrophin-related protein","volume":"360","author":"Tinsley","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2020.08.031_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0960-8966(91)90023-L","article-title":"Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle","volume":"1","author":"Khurana","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2020.08.031_bib27","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1073\/pnas.96.24.14025","article-title":"A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy","volume":"96","author":"Burton","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2020.08.031_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s004410000213","article-title":"Differential expression of dystrophin, utrophin, and dystrophin-associated proteins in human muscle culture","volume":"300","author":"Radojevic","year":"2000","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.omtn.2020.08.031_bib29","doi-asserted-by":"crossref","first-page":"45285","DOI":"10.1074\/jbc.M205177200","article-title":"A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle","volume":"277","author":"Weir","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2020.08.031_bib30","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1073\/pnas.0405972101","article-title":"Heregulin ameliorates the dystrophic phenotype in mdx mice","volume":"101","author":"Krag","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2020.08.031_bib31","doi-asserted-by":"crossref","first-page":"e26169","DOI":"10.1371\/journal.pone.0026169","article-title":"Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening","volume":"6","author":"Moorwood","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2020.08.031_bib32","doi-asserted-by":"crossref","first-page":"e19189","DOI":"10.1371\/journal.pone.0019189","article-title":"Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse","volume":"6","author":"Tinsley","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2020.08.031_bib33","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1371\/journal.pone.0000774","article-title":"Utrophin up-regulation by an artificial transcription factor in transgenic mice","volume":"2","author":"Mattei","year":"2007","journal-title":"PLoS ONE"},{"issue":"4 Pt A","key":"10.1016\/j.omtn.2020.08.031_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bbadis.2018.01.030","article-title":"Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice","volume":"1864","author":"Pisani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.omtn.2020.08.031_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1013067108","article-title":"Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice","volume":"108","author":"Amenta","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2020.08.031_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/hum.2015.088","article-title":"Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"28","author":"Ito","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-019-1307-9","article-title":"sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19\/miR-675\/let-7 and miR-21 pathways","volume":"10","author":"Morgoulis","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2020.08.031_bib38","doi-asserted-by":"crossref","first-page":"e29376","DOI":"10.1371\/journal.pone.0029376","article-title":"Translational regulation of utrophin by miRNAs","volume":"6","author":"Basu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2020.08.031_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1083\/jcb.200603039","article-title":"MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206","volume":"175","author":"Rosenberg","year":"2006","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2020.08.031_bib40","doi-asserted-by":"crossref","first-page":"e0182676","DOI":"10.1371\/journal.pone.0182676","article-title":"Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction","volume":"12","author":"Mishra","year":"2017","journal-title":"PLoS ONE"},{"issue":"R2","key":"10.1016\/j.omtn.2020.08.031_bib41","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","article-title":"Exon-skipping advances for Duchenne muscular dystrophy","volume":"27","author":"Echevarr\u00eda","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2020.08.031_bib42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2009.07.039","article-title":"Nanog is the gateway to the pluripotent ground state","volume":"138","author":"Silva","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib43","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A Web-based Tool for Identifying and Validating CRISPR\/Cas Off-target Sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2020.08.031_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","article-title":"Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice","volume":"115","author":"Ohlendieck","year":"1991","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2020.08.031_bib45","doi-asserted-by":"crossref","first-page":"23739","DOI":"10.1016\/S0021-9258(20)80440-2","article-title":"Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin)","volume":"268","author":"Roberds","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2020.08.031_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0014-5793(93)80602-Q","article-title":"Restoration of dystrophin-associated proteins in skeletal muscle of mdx mice transgenic for dystrophin gene","volume":"320","author":"Matsumura","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2020.08.031_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0014-5793(98)00251-8","article-title":"Effective restoration of dystrophin-associated proteins in\u00a0vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs","volume":"425","author":"Yuasa","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2020.08.031_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2008.012","article-title":"Long-term benefit of adeno-associated virus\/antisense-mediated exon skipping in dystrophic mice","volume":"19","author":"Denti","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib49","first-page":"210797","article-title":"The dystrophin-glycoprotein complex in the prevention of muscle damage","volume":"2011","author":"Gumerson","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.omtn.2020.08.031_bib50","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2020.08.031_bib51","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2020.08.031_bib52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omtn.2017.09.009","article-title":"CRISPR\/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects","volume":"9","author":"Zhang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2020.08.031_bib53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2020.08.031_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2020.08.031_bib55","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","article-title":"Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models","volume":"25","author":"Song","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2020.08.031_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtn.2020.08.031_bib57","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2016.192","article-title":"Prevention of Muscle Wasting by CRISPR\/Cas9-mediated Disruption of Myostatin In\u00a0Vivo","volume":"24","author":"Wei","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","article-title":"Spell Checking Nature: Versatility of CRISPR\/Cas9 for Developing Treatments for Inherited Disorders","volume":"98","author":"Wojtal","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2020.08.031_bib59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In\u00a0Vivo Target Gene Activation via CRISPR\/Cas9-Mediated Trans-epigenetic Modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2020.08.031_bib60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2020.08.031_bib61","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41409-019-0510-8","article-title":"CRISPR\/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation","volume":"54","author":"Daniel-Moreno","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtn.2020.08.031_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/cells7120253","article-title":"Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy","volume":"7","author":"Danisovic","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2020.08.031_bib63","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ymthe.2019.06.012","article-title":"AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice","volume":"27","author":"Nance","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib64","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.celrep.2019.03.105","article-title":"In Situ Modification of Tissue Stem and Progenitor Cell Genomes","volume":"27","author":"Goldstein","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2020.08.031_bib65","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/mt.2008.149","article-title":"Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin\/utrophin-deficient mice","volume":"16","author":"Odom","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2020.08.031_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5966\/sctm.2011-0001","article-title":"From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols","volume":"1","author":"Karumbayaram","year":"2012","journal-title":"Stem Cells Transl. Med."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253120302602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253120302602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:10:23Z","timestamp":1784808623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253120302602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":66,"alternative-id":["S2162253120302602"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2020.08.031","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2020.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020","name":"copyright","label":"Copyright"}]}}